MyFinsight
Home
Blog
About
Investments
$523,144K
(134.46%↑ Y/Y)
Cash and cash
equivalents
$138,268K
(35.84%↑ Y/Y)
Prepaid and other
current assets
$4,390K
(-57.60%↓ Y/Y)
Total current assets
$665,802K
(98.59%↑ Y/Y)
Other assets
$2,024K
(367.44%↑ Y/Y)
Property and equipment,
net
$27K
(22.73%↑ Y/Y)
Total assets
$667,853K
(98.93%↑ Y/Y)
Total liabilities and
stockholders equity
$667,853K
(98.93%↑ Y/Y)
Total stockholders
equity
$550,917K
(75.70%↑ Y/Y)
Total liabilities
$116,936K
Accumulated deficit
-$737,579K
(-90.10%↓ Y/Y)
Additional paid-in capital
$1,288,487K
(83.66%↑ Y/Y)
Senior secured term
loan, net
$97,617K
Total current
liabilities
$19,319K
(-12.87%↓ Y/Y)
Common stock, 0.0001
par value...
$9K
(50.00%↑ Y/Y)
Accrued liabilities
$18,253K
(-3.98%↓ Y/Y)
Accounts payable
$1,066K
(-66.31%↓ Y/Y)
Back
Back
Balance Sheet
Mineralys Therapeutics, Inc. (MLYS)
Mineralys Therapeutics, Inc. (MLYS)
source: myfinsight.com